Immediate Impact
11 by Nobel laureates 23 from Science/Nature 60 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Markus Eser being referenced
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+tumor cells
2015
RECRUIT-TandAbs ® : Harnessing the Immune System to Kill Cancer Cells
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Markus Eser | 647 | 160 | 143 | 163 | 17 | 945 | |
| Rosemarie Raffen | 768 | 71 | 113 | 108 | 12 | 938 | |
| Minyi Gu | 789 | 62 | 97 | 65 | 17 | 1.1k | |
| Lynda Dieckman | 686 | 58 | 93 | 80 | 15 | 905 | |
| Iwan Zimmermann | 693 | 114 | 218 | 88 | 18 | 951 | |
| Kap Lim | 694 | 95 | 148 | 65 | 31 | 1.1k | |
| Ten‐Yang Yen | 722 | 98 | 96 | 95 | 32 | 1.1k | |
| Suzanne Grothé | 580 | 148 | 155 | 69 | 20 | 835 | |
| Vasundara Srinivasan | 720 | 141 | 116 | 53 | 21 | 1.1k | |
| Sabina Gerber | 676 | 198 | 42 | 41 | 12 | 901 | |
| Melinda J. Faulkner | 495 | 48 | 108 | 64 | 11 | 771 |
All Works
Loading papers...